7 completed, 1 recruiting, 1 terminated, 1 unknown. 5 Phase 2, 3 Phase 1, 2 Phase 3, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Recruiting 1 |
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow florbenazine F 18: new trials by email Literature Review of florbenazine F 18 trials Research Report on florbenazine F 18
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months. [18F]AV-133 - Parkinson's Disease (PD), Healthy Control Subjects | Phase 2 | Recruiting | Michael J. Fox Foundation for Parkinson's Research | 50 | 2025-09-25 | 2026-09-21 |
| Targeting Monoaminergic Neuronal Networks in the Parkinsonian Patients After Carbon Monoxide Intoxication 18F-FP-(+)-DTBZ - Carbon Monoxide-induced Parkinsonism | Phase 3 | Unknown | Chang Gung Memorial Hospital | 25 | 2013-08-01 | 2016-06-01 |
| Evaluation of 18 F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass 18 F-FP-DTBZ, PET Scanning - Healthy Volunteers, Diabetes Mellitus, Type 1 | Early Phase 1 | Completed | Columbia University | 23 | 2013-07-02 | 2024-07-23 |
| Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls 18F-AV-133, 10% Arginine Hydrochloride-R-Gene 10 - Type 2 Diabetes | Phase 1 | Completed | Avid Radiopharmaceuticals | 40 | 2012-12-01 | 2015-11-13 |
| Positron-Emission Tomography With Vesicular Monoamine Transporter Ligand ([18F]-DTBZ) In Healthy Elderly And Young Subjects 18F-DTBZ AV-133 - Healthy | Phase 2 | Completed | Chang Gung Memorial Hospital | 25 | 2012-07-01 | 2017-09-25 |
| A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders 18F-AV-133 - Parkinson's Disease, Primary Parkinsonism | Phase 2 / Phase 3 | Completed | Avid Radiopharmaceuticals | 170 | 2012-04-01 | 2017-02-09 |
| Long-Term Vesicular Monoamine Transporter II Imaging and Clinical Assessment of Parkinson's Disease Progression 18F-DTBZ AV-133 - Parkinson Disease | Phase 2 | Completed | Chang Gung Memorial Hospital | 40 | 2011-11-01 | 2017-12-15 |
| A Trial of 18F-AV-133 Positron Emission Tomography (PET) 18F-AV-133 - Type 1 Diabetes, Type 2 Diabetes | Phase 1 | Terminated | Avid Radiopharmaceuticals | 19 | 2010-06-01 | 2020-01-13 |
| A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET) 18F-AV-133, 18F-AV-45 - Dementia With Lewy Bodies, Alzheimer's Disease | Phase 1 / Phase 2 | Completed | Avid Radiopharmaceuticals | 30 | 2010-03-01 | 2012-08-14 |
| Positron Emission Tomography (PET) Imaging of Pancreatic Beta-Cell Mass in Healthy and Type 1 Diabetic Patients 18F-FP-DTBZ (18F-AV-133), Arginine-hydrochloride - Diabetes Mellitus, Type 1 | Completed | Yale University | 16 | 2009-08-01 | 2012-07-23 |
Parkinson Disease (4) · Diabetes Mellitus, Type 1 (3) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 2 (2) · Alzheimer Disease (1) · Carbon Monoxide Poisoning (1) · Lewy Body Disease (1) · Parkinsonian Disorders (1)
Avid Radiopharmaceuticals (4) · Chang Gung Memorial Hospital (3) · Columbia University (1) · Michael J. Fox Foundation for Parkinson's Research (1) · Yale University (1)
United States (7) · Australia (1) · Taiwan (1)
Chiung-Chih Chang, M.D.; Ph.D (1) · Gary W Cline, Ph.D. (1) · Ken Marek, MD (1) · Kitt F Petersen, M.D. (1) · Paul Harris, PhD (1) · Richard Carson, Ph.D. (1) · Yu-Shin Ding, Ph.D. (1)
R01DK077493 (1)